Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Secukinumab for the Treatment of Deficiency of Interleukin 36 Receptor Antagonist in an Adolescent

Secukinumab for the Treatment of Deficiency of Interleukin 36 Receptor Antagonist in an Adolescent This case report describes the use of secukinumab for the treatment of deficiency of interleukin 36 receptor antagonist in an adolescent. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Secukinumab for the Treatment of Deficiency of Interleukin 36 Receptor Antagonist in an Adolescent

Loading next page...
 
/lp/american-medical-association/secukinumab-for-the-treatment-of-deficiency-of-interleukin-36-receptor-Pz7gYk9lnd
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/jamadermatol.2016.5705
pmid
28241175
Publisher site
See Article on Publisher Site

Abstract

This case report describes the use of secukinumab for the treatment of deficiency of interleukin 36 receptor antagonist in an adolescent.

Journal

JAMA DermatologyAmerican Medical Association

Published: May 22, 2017

References